Stocks News
Jazz Pharmaceuticals Stock Rises as Ziihera Shows Significant Survival Benefit in Gastric Cancer Trial
Jazz Pharmaceuticals (NASDAQ: JAZZ) announced on September 1, 2026, updated overall survival (OS) results from the phase III HERIZON-GEA-01 study, showing that...
